摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4,6-C6H2Me3CH=NCH2(2-ClC6H4) | 138956-85-1

中文名称
——
中文别名
——
英文名称
2,4,6-C6H2Me3CH=NCH2(2-ClC6H4)
英文别名
——
2,4,6-C6H2Me3CH=NCH2(2-ClC6H4)化学式
CAS
138956-85-1
化学式
C17H18ClN
mdl
——
分子量
271.79
InChiKey
ALUZEXLKZKFPCF-YBFXNURJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.88
  • 重原子数:
    19.0
  • 可旋转键数:
    3.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    12.36
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

反应信息

  • 作为反应物:
    描述:
    2,4,6-C6H2Me3CH=NCH2(2-ClC6H4)丙酮 为溶剂, 生成
    参考文献:
    名称:
    铂介导的芳基–芳基键形成和sp 3 C–H键激活†
    摘要:
    描述了一个新的过程,其中分子内氧化加成后是芳基-芳基键形成和sp 3 C-H键活化,从而导致六元铂环化。
    DOI:
    10.1039/c0dt00631a
点击查看最新优质反应信息

文献信息

  • Biaryl formation in the synthesis of endo and exo-platinacycles
    作者:Margarita Crespo、Mercè Font-Bardia、Teresa Calvet
    DOI:10.1039/c1dt10664c
    日期:——
    ArCHNCH2(2-XC6H4) containing a C–X bond at the ortho positions of the benzyl ring (Ar = 4-ClC6H4, X = Br (1d); Ar = 2,4,6-(CH3)3C6H2, X = Br (1e); Ar = 2,4,6-(CH3)3C6H2, X = Cl (1f); Ar = 2-CH3C6H4, X = Br (1h); Ar = 2,6-F2C6H3, X = Br (1i)) in refluxing toluene were studied. Several types of platinum(II) cyclometallated compounds containing a biaryl linkage were obtained: i) endo-five-membered with a Pt–C(sp2)
    的反应中的顺式- [PT 2(4-MEC 6 ħ 4)4(μ-SET 2)2 ]用双功能配体拱NCH 2(2-XC 6 H ^ 4)在含有C-X键的邻位的位置苄环(Ar = 4-ClC 6 H 4,X = Br(1d); Ar = 2,4,6-(CH 3)3 C 6 H 2,X = Br(1e); Ar = 2,4 ,6-(CH 3)3 C 6 H 2,X = Cl(1f); Ar = 2-CH 3 C 6 H 4,X = Br(1h); 回流时Ar = 2,6-F 2 C 6 H 3,X = Br(1i))甲苯被研究了。获得了几种类型的具有联芳基键的(II)环属化化合物:i)具有PT–C(sp 2)键的内五元键(2d,2h),ii)具有PT–C的内六元键C(sp 3)键(2e,2f)和iii)exo-5成员带有PT–C(sp 2)键(2i)。所形成的二芳基联动涉及一种用于属化环2I
  • Syntheses and mechanistic studies in the formation of endo- and exo-cyclometalated platinum compounds of N-benzylidenebenzylamines
    作者:Margarita Crespo、Manuel Martinez、Joaquim Sales、Xavier Solans、Merce Font-Bardia
    DOI:10.1021/om00039a038
    日期:1992.3
    The bifunctional ligands 2-XC6H4CH = NCH2-2'-X'C6H4, and related ligands with more substituents on the aryl rings, react with [Pt2Me4(mu-SMe2)2] to give cyclometalated complexes [PtMe2X-(SMe2)(C6H4CHNCH2-2'-X'C6H4)] (4) by oxidative addition of C-X bonds (X = Cl, Br), or complexes [PtMe(SMe2)(C6H4CHNCH2-2'-X'-C6H4)] 5 by orthometalation with loss of methane. In both types of compound the iminic functionality is endo to the cycle. Complexes 4 with an exocyclic structure are obtained only for X' = Br, or for X' = Cl when the ligand 2,4,6-C6H2(CH3)3CH = NCH2-2'-ClC6H4 is used. Compounds 5 with an exocyclic structure are not formed. The following order of reactivity has been deduced: C-Cl endo almost-equal-to C-Br exo > C-H endo > C-Cl exo >> C-H exo. Complexes 4 and 5 and the coordination compounds [PtMe2(SMe2)(2,4,6-C6H2(CH3)3CH = NCH2-2'-XC6H4)] (3) have been characterized by NMR spectroscopy. Complexes 4 react with PPh3 to give a displacement reaction of SMe2 for PPh3, and the resulting compounds have been characterized by NMR spectroscopy; the compound [PtMe2Cl(PPh3)(C6H3ClCHNCH2C6H5)] (6c) has been characterized crystallographically. Complex 6c crystallizes in the monoclinic space group P2(1)/a, with a = 17.677 (3) angstrom, b = 15.495 (3) angstrom, c = 11.371 (2) angstrom, beta = 104.59 (2)-degrees, and Z = 4. The kinetics of formation of compounds 4 and 5 has been studied. It is suggested that formation of coordination compounds 3 takes place prior to the oxidative addition, which follows first-order kinetics and occurs by a concerted mechanism.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫